These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31091052)

  • 1. Prospects of intranasal insulin for correction of cognitive impairments, in particular those associated with diabetes mellitus.
    Surkova EV; Derkach KV; Bespalov AI; Shpakov AO
    Probl Endokrinol (Mosk); 2019 May; 65(1):57-65. PubMed ID: 31091052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.
    Benedict C; Frey WH; Schiöth HB; Schultes B; Born J; Hallschmid M
    Exp Gerontol; 2011; 46(2-3):112-5. PubMed ID: 20849944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal Insulin Prevents Anesthesia-induced Cognitive Impairments in Aged Mice.
    Li X; Run X; Wei Z; Zeng K; Liang Z; Huang F; Ke D; Wang Q; Wang JZ; Liu R; Zhang B; Wang X
    Curr Alzheimer Res; 2019; 16(1):8-18. PubMed ID: 30381076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism.
    Ott V; Benedict C; Schultes B; Born J; Hallschmid M
    Diabetes Obes Metab; 2012 Mar; 14(3):214-21. PubMed ID: 21883804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale.
    Galindo-Mendez B; Trevino JA; McGlinchey R; Fortier C; Lioutas V; Novak P; Mantzoros CS; Ngo L; Novak V
    Contemp Clin Trials; 2020 Feb; 89():105934. PubMed ID: 31923471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Insulin for Alzheimer's Disease.
    Hallschmid M
    CNS Drugs; 2021 Jan; 35(1):21-37. PubMed ID: 33515428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.
    Guo Z; Chen Y; Mao YF; Zheng T; Jiang Y; Yan Y; Yin X; Zhang B
    Sci Rep; 2017 Apr; 7():45971. PubMed ID: 28382978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hot Spots for the Use of Intranasal Insulin: Cerebral Ischemia, Brain Injury, Diabetes Mellitus, Endocrine Disorders and Postoperative Delirium.
    Shpakov AO; Zorina II; Derkach KV
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and clinical implications of intranasal insulin administration to the central nervous system.
    Santiago JCP; Hallschmid M
    Exp Neurol; 2019 Jul; 317():180-190. PubMed ID: 30885653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review.
    Avgerinos KI; Kalaitzidis G; Malli A; Kalaitzoglou D; Myserlis PG; Lioutas VA
    J Neurol; 2018 Jul; 265(7):1497-1510. PubMed ID: 29392460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.
    Claxton A; Baker LD; Hanson A; Trittschuh EH; Cholerton B; Morgan A; Callaghan M; Arbuckle M; Behl C; Craft S
    J Alzheimers Dis; 2015; 44(3):897-906. PubMed ID: 25374101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of insulin in trigeminal nerve and brain after intranasal administration.
    Lochhead JJ; Kellohen KL; Ronaldson PT; Davis TP
    Sci Rep; 2019 Feb; 9(1):2621. PubMed ID: 30796294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction.
    Kamei N; Okada N; Ikeda T; Choi H; Fujiwara Y; Okumura H; Takeda-Morishita M
    Sci Rep; 2018 Dec; 8(1):17641. PubMed ID: 30518944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an Enhanced Nose-to-Brain Delivery of Insulin on Mild and Progressive Memory Loss in the Senescence-Accelerated Mouse.
    Kamei N; Tanaka M; Choi H; Okada N; Ikeda T; Itokazu R; Takeda-Morishita M
    Mol Pharm; 2017 Mar; 14(3):916-927. PubMed ID: 28094952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice.
    Mao YF; Guo Z; Zheng T; Jiang Y; Yan Y; Yin X; Chen Y; Zhang B
    Aging Cell; 2016 Oct; 15(5):893-902. PubMed ID: 27457264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
    Stanley M; Macauley SL; Holtzman DM
    J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal insulin administration: a method for dissociating central and peripheral effects of insulin.
    Reger MA; Craft S
    Drugs Today (Barc); 2006 Nov; 42(11):729-39. PubMed ID: 17171192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence.
    Freiherr J; Hallschmid M; Frey WH; Brünner YF; Chapman CD; Hölscher C; Craft S; De Felice FG; Benedict C
    CNS Drugs; 2013 Jul; 27(7):505-14. PubMed ID: 23719722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Insulin Resistance to Treat Cognitive Dysfunction.
    Tyagi A; Pugazhenthi S
    Mol Neurobiol; 2021 Jun; 58(6):2672-2691. PubMed ID: 33483903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders.
    Hallschmid M; Benedict C; Schultes B; Perras B; Fehm HL; Kern W; Born J
    Regul Pept; 2008 Aug; 149(1-3):79-83. PubMed ID: 18442862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.